These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11881506)

  • 1. [Role of dysbacteriosis in the formation of chronic noninfectious pathology in children].
    Voevodin DA; Rozanova GN; Stenina MA; Cheredeev AN
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):88-93. PubMed ID: 11881506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenetic role of dysbacteriosis in the development of complications of type 1 diabetes mellitus in children.
    Rozanova GN; Voevodin DA; Stenina MA; Kushnareva MV
    Bull Exp Biol Med; 2002 Feb; 133(2):164-6. PubMed ID: 12428285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of intestinal dysbacteriosis in children with diabetes mellitus].
    Voronin AA; Taranenko LA; Sidorenko SV
    Antibiot Khimioter; 1999; 44(3):22-4. PubMed ID: 10382034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
    Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM
    Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dysbacteriosis and immunopathological process].
    Voevodin DA; Rozanova GN; Stenina MA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (2):89-92. PubMed ID: 15881951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intestinal dysbacteriosis in children].
    Iatsyk GV; Gribakin SG
    Feldsher Akush; 1988 Mar; 53(3):36-9. PubMed ID: 3378637
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bacterial endotoxinemia in children with intestinal dysbacteriosis].
    Lykova EA; Bondarenko VM; Vorob'ev AA; Sudzhan EV; Minaev VI; Malikov VE
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):67-70. PubMed ID: 10851996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysbiotic conditions and their management].
    Bondarenko VM; Gracheva NM
    Vestn Ross Akad Med Nauk; 2005; (12):24-9. PubMed ID: 16404979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotherapy of intestinal dysbacteriosis].
    Chekman IS
    Lik Sprava; 2000; (7-8):6-11. PubMed ID: 16786636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of acipole in prevention of enteric dysbacteriosis due to antibacterial therapy].
    Oleĭnichenko EV; Mitrokhin SD; Nonikov VE; Minaev VI
    Antibiot Khimioter; 1999; 44(1):23-5. PubMed ID: 10095921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe forms of acute pneumonia with a protracted course accompanied by liver and intestinal dysfunction and dysbacteriosis in young children].
    Fedenko NN; Fedenko SI
    Pediatriia; 1988; (11):36-41. PubMed ID: 3226801
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of intestinal dysbacteriosis in gynecologic patients].
    Baskakov VP; Tsvelev IuV; Tumanov IP
    Akush Ginekol (Mosk); 1980 Sep; (9):40-2. PubMed ID: 7435845
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correction of intestinal dysbacteriosis with biological preparations in acute leukemia].
    Tolkacheva TV; Abakumov EM; Martynova VA; Golosova TV
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):29-33. PubMed ID: 7279892
    [No Abstract]   [Full Text] [Related]  

  • 14. [The principles of the combined therapy of intestinal dysbacteriosis].
    Krylov VP; Orlov VG; Malysheva TV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):64-6. PubMed ID: 9783405
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute pyelonephritis associated with intestinal dysbacteriosis: incidence and enhancement of efficiency of treatment].
    Ukhal' EM; Ukhal' MI
    Lik Sprava; 2000 Sep; (6):74-7. PubMed ID: 11452928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MICROBIOLOGICAL AND IMMUNOLOGICAL ASSESSMENT OF A COMPLEX OF THERAPEUTIC-PREVENTIVE MEASURES FOR CHRONIC CATARRHAL GINGIVITIS IN CHILDREN WITH DIABETES MELLITUS.
    Kotelban А; Moroz P; Hrynkevych L; Romaniuk D; Muryniuk T
    Georgian Med News; 2019 Sep; (294):72-76. PubMed ID: 31687953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenetic role of intestinal microbiocenosis in the pathogenesis of hereditary myodystrophy].
    Voevodin DA; Sitnikov VF; Stenina MA; Rozanova GN; Skripnik AIu; Cheredeev AN
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (5):68-70. PubMed ID: 11871307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics: delineation of prophylactic and therapeutic benefits.
    Kaur IP; Kuhad A; Garg A; Chopra K
    J Med Food; 2009 Apr; 12(2):219-35. PubMed ID: 19459724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of sporulating bacteria in treating patients with dysbacteriosis].
    Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA
    Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysbacteriosis and preparations with probiotic function].
    Bondarenko VM; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (1):84-92. PubMed ID: 15024992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.